Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duarte

Showing results (781-790 of 824) with videos related to

Pageof 83
Sort By:
Experimental Parasitology|March 26, 2016
Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensisMariana C Duarte, Grasiele S V Tavares, Diogo G Valadares, et al.
Microbial Pathogenesis|June 21, 2017
Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasisLourena E Costa, Beatriz C S Salles, Thaís T O Santos, et al.
Parasitology|May 31, 2019
Screening diagnostic candidates from <i>Leishmania infantum</i> proteins for human visceral leishmaniasis using an immunoproteomics approachDaniela P Lage, Fernanda Ludolf, Patrícia C Silveira, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 17, 2018
Vaccination with a CD4<sup>+</sup> and CD8<sup>+</sup> T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Correction: Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral LeishmaniasisVivian T Martins, Miguel A Chávez-Fumagalli, Lourena E Costa, et al.
International Journal of Nanomedicine|March 15, 2014
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery systemTatiana G Ribeiro, Miguel A Chávez-Fumagalli, Diogo G Valadares, et al.
Acta Tropica|March 15, 2017
Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c miceThaís T O Santos, Vívian T Martins, Daniela P Lage, et al.
Cellular Immunology|June 7, 2018
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humansPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Molecules (Basel, Switzerland)|June 10, 2023
Antinociceptive Effect of a p-Cymene/β-Cyclodextrin Inclusion Complex in a Murine Cancer Pain Model: Characterization Aided through a Docking StudyWagner B R Santos, Lícia T S Pina, Marlange A de Oliveira, et al.
Cellular Immunology|June 13, 2017
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humansAna Maria R S Carvalho, Lourena E Costa, Beatriz C S Salles, et al.
Pageof 83

Showing results (781-790 of 824) with videos related to

Sort By:
Pageof 83
Experimental Parasitology|March 26, 2016
Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensisMariana C Duarte, Grasiele S V Tavares, Diogo G Valadares, et al.
Microbial Pathogenesis|June 21, 2017
Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasisLourena E Costa, Beatriz C S Salles, Thaís T O Santos, et al.
Parasitology|May 31, 2019
Screening diagnostic candidates from <i>Leishmania infantum</i> proteins for human visceral leishmaniasis using an immunoproteomics approachDaniela P Lage, Fernanda Ludolf, Patrícia C Silveira, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 17, 2018
Vaccination with a CD4<sup>+</sup> and CD8<sup>+</sup> T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Correction: Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral LeishmaniasisVivian T Martins, Miguel A Chávez-Fumagalli, Lourena E Costa, et al.
International Journal of Nanomedicine|March 15, 2014
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery systemTatiana G Ribeiro, Miguel A Chávez-Fumagalli, Diogo G Valadares, et al.
Acta Tropica|March 15, 2017
Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c miceThaís T O Santos, Vívian T Martins, Daniela P Lage, et al.
Cellular Immunology|June 7, 2018
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humansPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Molecules (Basel, Switzerland)|June 10, 2023
Antinociceptive Effect of a p-Cymene/β-Cyclodextrin Inclusion Complex in a Murine Cancer Pain Model: Characterization Aided through a Docking StudyWagner B R Santos, Lícia T S Pina, Marlange A de Oliveira, et al.
Cellular Immunology|June 13, 2017
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humansAna Maria R S Carvalho, Lourena E Costa, Beatriz C S Salles, et al.
Pageof 83